Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion

Experimental Hematology

Volumn 29, Issue 2, 2001, Pages 244-255

  Devine, Steven M ^a   Bartholomew, Amelia M ^a   Mahmud, Nadim ^a   Nelson, Mary ^a   Patil, Sheila ^d   Hardy, Wayne ^d   Sturgeon, Cord ^a   Hewett, Terry ^c   Chung, Theodore ^a   Stock, Wendy ^a   Sher, Dorie ^a   Weissman, Scott ^a   Ferrer, Karen ^b,d   Mosca, Joseph ^d   Deans, Robert ^d   Moseley, Annemarie ^d   Hoffman, Ronald ^a  

^a Department of Medicine ^*  (United States)

^b Depts of Medicine and Psychiatry   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d OSIRIS THERAPEUTICS INC   (United States)

Author keywords

Gene therapy; Mesenchymal stem cell; Primate; Transplantation

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BABOON; BONE MARROW; CELL DIFFERENTIATION; CELL TRANSFER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MESENCHYME; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; STROMA CELL; TOXICITY;

ALKALINE PHOSPHATASE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; ANTIGENS, CD45; BONE MARROW; CELL SEPARATION; CELLS, CULTURED; DNA, RECOMBINANT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GREEN FLUORESCENT PROTEINS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LUMINESCENT PROTEINS; MALE; MESODERM; PAPIO; POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSFECTION; TRANSGENES;

ANIMALIA; PAPIO; PAPIO ANUBIS; PAPIO HAMADRYAS; PRIMATES;

EID: 0035144015     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00635-4     Document Type: Article

References (56)

1. Multilineage potential of adult human mesenchymal stem cells
2. Mesenchymal stem cells; no longer second class marrow citizens
3. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation
4. Isolation and characterization of osteoblast precursor cells from human bone marrow
5. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells
6. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies
7. Human mesenchymal stem cells can enhance human CD34+ cell repopulating of NOD/SCID mice
8. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta
9. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts
10. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains
11. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
12. Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice
13. + cells
14. Cytokines released in vitro by stromal cells from autologous bone marrow transplant patients with lymphoid malignancy
15. Bone marrow stromal function from patients after bone marrow transplantation
16. Reduced expression of vascular cell adhesion molecule-1 on bone marrow stromal cells isolated from marrow transplant recipients correlates with a reduced capacity to support human B lymphopoiesis in vitro
17. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients
18. Is the marrow stroma transplantable?
19. Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man
20. Host origin of marrow stromal cells following allogeneic bone marrow transplantation
21. Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation
22. Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans
23. Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia
24. The origin of stromal cells in patients treated by bone marrow transplantation
25. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases
26. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections
27. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation
28. Ex vivo expansion of autologous bone marrow CD34(+) cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons
29. Human and animal mesenchymal progenitor cells from bone marrow; identification of serum for optimal selection and proliferation
30. Characterization of cells with osteogenic potential from human marrow
31. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors
32. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos
33. A modified cage to minimize catheter contamination in the chronically catheterized baboon
34. Conservation of human chromosome 18 in baboons (Papio hamadryas); a linkage map of eight human microsatellites
35. Chinese population data on three tetrameric short tandem repeat loci-HUMTHO1, TPOX, and CSF1PO-derived using multiplex PCR and manual typing
36. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105)
37. Late complications following total-body irradiation and bone marrow rescue in mice; predominance of glomerular nephropathy and hemolytic anemia
38. Hemolytic uremic syndrome after allogeneic or autologous hematopoietic stem cell transplantation for childhood malignancies
39. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy
40. Osteoblast specific gene expression after transplantation of marrow cells; implications for skeletal gene therapy
41. Biology of bone marrow stroma
42. Retroviral-mediated marker gene transfer in hematopoiesis-supportive marrow stromal cells
43. Retroviral-mediated gene transfer into human bone marrow stromal cells; studies of efficiency and in vivo survival in SCID mice
44. Gene therapy model for stromal precursor cells of hematopoietic microenvironment
45. Transplantation of stromal cells transduced with the human IL3 gene to stimulate hematopoiesis in human fetal bone grafts in non-obese, diabetic-severe combined immunodeficiency mice
46. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells
47. Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX
48. Bone marrow stromal cells as targets for gene therapy of hemophilia A
49. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors
50. Human erythropoietin gene delivery using adult mesenchymal stem cells can prevent drug induced anemia in NOD/SCID mouse model
51. RT-PCR and chemiluminescent ELISA for detection of enteroviruses
52. Screening for single nucleotide polymorphisms using branch migration inhibition in PCR amplified DNA
53. Improved hematopoiesis in anemic Sl/Sld mice by splenectomy and therapeutic transplantation of a hematopoietic microenvironment
54. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells
55. Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero